Funds multidisciplinary research on how sleep and circadian biology contribute to neurodegenerative diseases like Alzheimer’s, Lewy body diseases, and PSP.
Funder: Alzheimer's Association
Due Dates: January 29, 2025 (Letter of Intent) | May 14, 2025 (Full application)
Funding Amounts: Up to $500,000 total for up to 2 years; anticipated range $200,000–$500,000 per award; 4–6 awards expected
Summary: Funds multidisciplinary research on how sleep and circadian biology contribute to neurodegenerative diseases, including Alzheimer’s, Lewy body diseases, and PSP.
Key Information: Letter of Intent is required and must be submitted online; only invited applicants may submit full proposals.
The Sleep Contributions to Neurodegeneration (SCN) Grant Program, a collaboration between the Alzheimer's Association, The Michael J. Fox Foundation for Parkinson’s Research, and CurePSP, supports research that advances understanding of the role of sleep and related biology—such as circadian rhythms—in neurodegenerative diseases. The program emphasizes multidisciplinary, team-based science to address how sleep impacts neurodegeneration both as a cause and a consequence, and seeks projects that integrate systems or holistic approaches, advanced sleep measurement tools, and data sharing. Priority is given to studies that involve collaboration across disciplines or institutions and those that incorporate sleep measures into ongoing research or leverage existing datasets.